Haley Sisel

Haley Sisel

Auto-generated profile, based on publicly available information

Haley Sisel

Key Populations Program, Center for Public Health and Human Rights, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2023 in Southern African Journal of HIV Medicine
Verified
Journal Article
Open access
PDF file
RPRefilwe Nancy Phaswana-Mafuya
Refilwe Nancy Phaswana-Mafuya
EPEdith Phalane
Edith Phalane
HSHaley Sisel
Haley Sisel
LMLifutso Motsieloa
Lifutso Motsieloa
KJKatherine Journeay
Katherine Journeay
PRPholokgolo Ramothwala
Pholokgolo Ramothwala
The Southern African Journal of HIV Medicine is focused on HIV/AIDS treatment, prevention and related topics relevant to clinical and public health practice. The purpose of the journal is to disseminate original research results and support high-level learning related to HIV Medicine. It publishes original research articles, editorials, case reports/case series, reviews of state-of-the-art clinical practice and correspondence.

22 January 2025 in JMIR Research Protocols
Verified
Journal Article
Open access
RPRefilwe Nancy Phaswana-Mafuya
Refilwe Nancy Phaswana-Mafuya
EPEdith Phalane
Edith Phalane
ARAmrita Rao
Amrita Rao
KWKalai Willis
Kalai Willis
KRKatherine Rucinski
Katherine Rucinski
SBStefan Baral
Stefan Baral
Background: In South Africa, there is no centralized HIV surveillance system where key populations (KPs) data, including gay men and other men who have sex with men, female sex workers, transgender persons, people who use drugs, and incarcerated persons, are stored in South Africa despite being on higher risk of HIV acquisition and transmission than the general population. Data on KPs are being collected on a smaller scale by numerous stakeholders and managed in silos. There exists an opportunity to harness a variety of data, such as empirical, contextual, observational, and programmatic data, for evaluating the potential impact of HIV responses among KPs in South Africa. Objective: This study aimed to leverage and harness big heterogeneous data on HIV among KPs and harmonize and analyze it to inform a targeted HIV response for greater impact in Sub-Saharan Africa. Methods: The Boloka data repository initiative has 5 stages. There will be engagement of a wide range of stakeholders to facilitate the acquisition of data (stage 1). Through these engagements, different data types will be collated (stage 2). The data will be filtered and screened to enable high-quality analyses (stage 3). The collated data will be stored in the Boloka data repository (stage 4). The Boloka data repository will be made accessible to stakeholders and authorized users (stage 5). Results: The protocol was funded by the South African Medical Research Council following external peer reviews (December 2022). The study received initial ethics approval (May 2022), renewal (June 2023), and amendment (July 2024) from the University of Johannesburg (UJ) Research Ethics Committee. The research team has been recruited, onboarded, and received non–web-based internet ethics training (January 2023). A list of current and potential data partners has been compiled (January 2023 to date). Data sharing or user agreements have been signed with several data partners (August 2023 to date). Survey and routine data have been and are being secured (January 5, 2023). In (September 2024) we received Ghana Men Study data. The data transfer agreement between the Pan African Centre for Epidemics Research and the Perinatal HIV Research Unit was finalized (October 2024), and we are anticipating receiving data by (December 2024). In total, 7 abstracts are underway, with 1 abstract completed the analysis and expected to submit the full article to the peer-reviewed journal in early January 2024. As of March 2025, we expect to submit the remaining 6 full articles. Conclusions: A truly “complete” data infrastructure that systematically and rigorously integrates diverse data for KPs will not only improve our understanding of local epidemics but will also improve HIV interventions and policies. Furthermore, it will inform future research directions and become an incredible institutional mechanism for epidemiological and public health training in South Africa and Sub-Saharan Africa. International Registered Report Identifier (IRRID): DERR1-10.2196/63583

22 October 2026 in AIDS and Behavior
Verified
Journal Article
Open access
PDF file
ISIvan Segawa
Ivan Segawa
HSHaley Sisel
Haley Sisel
CKCatherine Kyampire
Catherine Kyampire
RWRose Wilcher
Rose Wilcher
KCKyria Louis Charles
Kyria Louis Charles
VFVirginia Fonner
Virginia Fonner
As pre-exposure prophylaxis (PrEP) options expand, providers play a critical role in supporting clients to select the method that best meets their needs. We examined how client–provider interactions during PrEP choice counselling influenced women’s autonomous decision-making and early continuation on PrEP. CATALYST was a mixed-methods study that delivered an informed choice of oral PrEP, the dapivirine vaginal ring, and injectable cabotegravir among women attending 28 public-sector facilities in Kenya, Lesotho, South Africa, Uganda, and Zimbabwe. We analysed cohort data collected between June 2024 and January 2025 and adapted a family planning Autonomous Decision-Making (ADM) scale into a six-item PrEP-specific measure (PrEP-ADM scale). Factor analysis assessed scale structure, and logistic regression identified factors associated with fully autonomous decision-making (PrEP-ADM score of 18/18) and refilling PrEP within three months. Twenty-six in-depth interviews explored counselling experiences. Among 2,488 women, 92% reported fully autonomous decision-making. Two subscales were identified: “communicating information” and “supporting informed choice”. Women in sero-different partnerships had higher odds of reporting fully autonomous decision-making (adjusted odds ratio [aOR]: 1.63, 95% CI: 1.11–2.39), whereas pregnant (aOR: 0.29, 95% CI: 0.17–0.47) and breastfeeding women (aOR: 0.46, 95% CI: 0.28–0.76) had lower odds. Autonomous decision-making was not associated with PrEP refill. Qualitative findings confirmed clear information exchange and supportive counselling, although pregnant and breastfeeding women described more constrained choices. High levels of perceived autonomous decision-making were observed, though further work is needed to refine these measures and identify the essential elements of informed PrEP choice counselling.